Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

A Multicenter Research on the Effects of Substitution of Hospital Ward Care From Medical Doctors to Physician Assistants

13 mai 2015 mis à jour par: Radboud University Medical Center

Worthy Assistants: Does Substituting Hospital Ward Care From Medical Residents to Physician Assistants Result in Cost Savings?

Reallocation of healthcare is one solution to the problems healthcare is facing. In the Netherlands reallocation of care to Physician Assistants (PAs) hasn't adequately been studied. Given the growing number of PAs, it is essential to evaluate the effectiveness and efficacy of (Dutch) PA services.

This multicenter matched-controlled study aims to evaluate the (cost) effectiveness of substitution of hospital ward care from medical doctors (MDs) to PAs. The traditional model in which the role of house officer is taken by medical doctors MD model) will be compared with a mixed model in which a PA functions as house officer together with a medical doctor (PA/MD model). Hospital wards will be matched on medical specialism and hospital type (i.e. academic;non-academic). On the basis of USA studies, it is hypothesized that the mixed PA/MD model compared to the MD model reduces the costs of healthcare, while improving or maintaining the clinical outcomes, patients and provider satisfaction, and continuity and quality of care.

Primary research question:

• What is the effect of 'mixed PA/MD model' compared with 'MD model' on efficiency of care?

Secondary research questions:

  • What is the effect of 'mixed PA/MD model' compared with 'MD model' on clinical and patients outcomes?
  • What is the effect of 'mixed PA/MD model' compared with 'MD model' on continuity of care?
  • What is the effect of 'mixed PA/MD model' compared with 'MD model' on nurses and (specialist) medicals doctor experiences?
  • What are the barriers and facilitating factors considering the implementation of PAs as house officer?

Aperçu de l'étude

Statut

Complété

Les conditions

Intervention / Traitement

Type d'étude

Observationnel

Inscription (Réel)

2382

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

      • Utrecht, Pays-Bas
        • UMC Utrecht
    • Drenthe
      • Emmen, Drenthe, Pays-Bas
        • Scheper Ziekenhuis
    • Friesland
      • Heerenveen, Friesland, Pays-Bas, 8441 PW
        • Tjongerschans Ziekenhuis
    • Gelderland
      • Apeldoorn, Gelderland, Pays-Bas
        • Gelre Ziekenhuizen
      • Arnhem, Gelderland, Pays-Bas, 6800 TA
        • Rijnstate
      • Doetinchem, Gelderland, Pays-Bas
        • Slingeland Ziekenhuis
      • Ede, Gelderland, Pays-Bas
        • Ziekenhuis de Gelderse Vallei
      • Nijmegen, Gelderland, Pays-Bas, 6500HB
        • Radboud University Nijmegen Medical Centre
      • Nijmegen, Gelderland, Pays-Bas, 6532 SZ
        • Canisius Wilhelmina Ziekenhuis
      • Winterswijk, Gelderland, Pays-Bas
        • Streekziekenhuis Koningin Beatrix
    • Limburg
      • Roermond, Limburg, Pays-Bas, 6043 CV
        • Laurentius ziekenhuis
      • Roermond, Limburg, Pays-Bas
        • Laurentius ziekenhuis
      • Sittard, Limburg, Pays-Bas
        • Orbis Medisch Centrum
      • Venlo, Limburg, Pays-Bas, 5912 BL
        • VieCuri Medical Center
    • Noord-Brabant
      • Bergen op Zoom, Noord-Brabant, Pays-Bas, 4624 VT
        • Lievensberg ziekenhuis
      • Den Bosch, Noord-Brabant, Pays-Bas
        • Jeroen Bosch Ziekenhuis
      • Helmond, Noord-Brabant, Pays-Bas
        • Elkerliek Ziekenhuis
      • Roosendaal, Noord-Brabant, Pays-Bas, 4708 AE
        • Fransiscus Ziekenhuis
      • Tilburg, Noord-Brabant, Pays-Bas
        • St. Elisabeth Ziekenhuis
      • Tilburg, Noord-Brabant, Pays-Bas
        • TweeSteden Ziekenhuis
    • Zeeland
      • Dirksland, Zeeland, Pays-Bas
        • Van Weel Bethesda Ziekenhuis
    • Zuid-Holland
      • Delft, Zuid-Holland, Pays-Bas
        • Reinier de Graaf Gasthuis
      • Den Haag, Zuid-Holland, Pays-Bas
        • HagaZiekenhuis
      • Den Haag, Zuid-Holland, Pays-Bas
        • Medisch Centrum Haaglanden

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans et plus (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

Méthode d'échantillonnage

Échantillon non probabiliste

Population étudiée

Hospital Ward Care: all patients (age 18 years or older) admitted to a hospital ward will be included in the study.

La description

Inclusion criteria:

• Wards using a mixed PA/physician model (with PA ward coverage of at least 50% of the available ward hours per week, during dayshifts on weekdays) or a physician model (daily coverage by a (specialized medical doctor)

Exclusion criteria on ward level:

  • Wards from specialty hospitals
  • Wards with only PAs in training
  • Wards with a nurse practitioner (NP) in the role of house officer (NP, NP/MD or PA/NP/MD model)
  • Pediatric and psychiatric wards, intensive care units

Exclusion criteria on patient level:

  • Terminal patients
  • Not fluent in Dutch language
  • Age < 18 years
  • Patients in daycare

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

Cohortes et interventions

Groupe / Cohorte
Intervention / Traitement
MD model
Hospital wards at which ward care is provided only by Medical Doctors (MDs)
PA/MD model
Hospital wards at which ward care is provided by both Physician Assistants (PAs) and Medical Doctors (MDs)
Intervention wards are hospital wards at which ward care is provided by both Physician Assistants (PAs) and Medical Doctors (MDs)

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Length of hospital stay
Délai: Patients will be followed for the duration of hospital stay; an expected average of 6 days
The difference between date of discharge and date of admission
Patients will be followed for the duration of hospital stay; an expected average of 6 days

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Efficiency of care
Délai: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
Relevant costs associated with the principal admission (length of hospital stay, resource use, consultation of health care suppliers, salaries) and costs that occurred after discharge (unplanned readmission, presentation at emergency departments, visits of general practitioner, required home care) will be calculated, considering a follow-up period from admission until 1 month after discharge. All volumes will be collected in detail at an individual patient level, primarily from medical patient records and patient and care provider questionnaires. Medical costs will be calculated by multiplying the volumes of healthcare use with corresponding unit prices, derived from the Dutch Manual for Costing Research
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
Quality of hospital ward care
Délai: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
To estimate the quality of ward care, a set of objective indicators has been developed through literature review and clinical input from a physician panel. We have selected both clinical indicators and process indicators, with a follow-up period of maximum 1 month after discharge. Clinical indicators were based on the national set of indicators for quality of hospital care from the Dutch Health Care Inspectorate (IGZ) and consider the incidences of inhospital mortality, cardiopulmonary resuscitation, unplanned readmission, presentation at emergency department after discharge,unplanned transfer to Intensive Care Unit, development of hospital infections, pressure sore and fever, and pain scores . Process indicators are the number of days between a patients discharge and the date of written turnover to general practitioner or other hospital, and acquaintance with the patient within 24 hours after admission
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days
Patient quality of life
Délai: Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days. Measurements of quality of life will be performed at hospital admission, hospital discharge and 1 month after discharge
Patient experienced quality of life will be measured by the EQ-5D questionnaire. This questionnaire will be distributed at hospital admission, hospital discharge, and 1 month after discharge
Patients will be followed from hospital admission till 1 month after discharge; an expected average of 1 month and 6 days. Measurements of quality of life will be performed at hospital admission, hospital discharge and 1 month after discharge
Feasibility, barriers and facilitators
Délai: 12 months
Semi-structured (group)interviews will be held with PAs, (specialized) medical doctors, ward nurses and heads of the departments. The interviews will cover experiences with the utilized ward model, communication between professionals, satisfaction, and barriers and facilitators related to the utilization of the 'mixed PA/MD model'. Specific attention will be paid to the role and functioning of PAs
12 months
Care provider experiences
Délai: 12 months

Job satisfaction, subjective workload and stress reaction of PAs, (specialized) medical doctors and ward nurses will be measured by a self-administered questionnaire. Job satisfaction will be measured by an adapted version of the job satisfaction questionnaire of McCranie, stress reaction will be measured by a short version of the General Health Questionnaire (GHQ-12)

Objective workload will be measured by calculating the ratio between number of working hours at the hospital ward, and the number of patients the PA or medical doctor is responsible for.

12 months
Continuity of care
Délai: 4 months
Continuity of care will be measured by deriving the number of rotations of PAs and medical doctors at the hospital ward from work schedules, which will be assessed during 4 weeks, spread over 4 months
4 months
Patient experiences with hospital ward care
Délai: Patients will be followed for the duration of hospital stay; an expected average of 6 days. Measurement of patient experiences will be performed at discharge
Patient experiences with medical ward care will be assessed by a self-administered questionnaire at discharge. This questionnaire focuses on satisfaction with communication, experienced continuity of care and cooperation, and the patients view on the medical competencies of the ward care provider
Patients will be followed for the duration of hospital stay; an expected average of 6 days. Measurement of patient experiences will be performed at discharge

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Chercheur principal: M.G.H. Laurant, PhD, IQ healthcare, UMC St Radboud

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 avril 2013

Achèvement primaire (Réel)

1 mai 2015

Achèvement de l'étude (Réel)

1 mai 2015

Dates d'inscription aux études

Première soumission

5 avril 2013

Première soumission répondant aux critères de contrôle qualité

18 avril 2013

Première publication (Estimation)

19 avril 2013

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

14 mai 2015

Dernière mise à jour soumise répondant aux critères de contrôle qualité

13 mai 2015

Dernière vérification

1 mai 2015

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 80-82310-97-12094

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner